AdvoCare is the new title sponsor of the Texas Bowl, a postseason collegiate football game. Owned and operated by ESPN Regional Television (ERT), a subsidiary of ESPN, and managed locally by Lone Star Sports & Entertainment (LSSE), the Houston-based event will now be known as the AdvoCare Texas Bowl. The initial agreement is for three years through the 2016 bowl game and aligns with their sponsorship of the AdvoCare Texas Kickoff – a Labor Day weekend college football game.
AdvoCare to Become New Title Sponsor of Texas Bowl
AdvoCare is the new title sponsor of the Texas Bowl, a postseason collegiate football game
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Research & Development
As omega-3 innovation evolves, brands are exploring new phospholipid systems beyond traditional krill oil
NBR spoke to Naturmega about the emergence of next-generation phospholipid omega-3 solutions, changing market expectations and why the future of omega innovation may increasingly revolve around smarter lipid architecture rather than source alone
Research & Development
ZeroLyte hydrates twice as fast as water in first sugar-free electrolyte clinical trial
ASU's Hydration Science Lab confirms Trace Minerals' ZeroLyte improves post-exercise fluid retention at every measured time point — a clinically validated edge for sports nutrition formulators and health-conscious consumers
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Research & Development
Nootropics Depot CEO argues sports hydration industry is still formulating for a cholera crisis
A new white paper from supplement company Nootropics Depot challenges the electrolyte category's reliance on a 1970s formula designed for diarrhoeal dehydration and proposes a science-led rethink for the modern sports nutrition market
Research & Development
Epax cetoleic 2040 reduces LDL-cholesterol in overweight adults, clinical trial finds
Clinical study shows supplementation with EPAX cetoleic 2040 reduces LDL-cholesterol by 7% in overweight and obese adults after eight weeks, highlighting potential cardiovascular health benefits